Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.
Interstitial Lung Disease (ILD): In the PHAROS trial, 1 patient (1%) receiving MEKTOVI with BRAFTOVI developed pneumonitis. Assess new or progressive unexplained pulmonary symptoms or findings for ...
Charcoal tablets are considered a home remedy for diarrhea and a first-aid measure for poisoning. But when are they really ...
Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback